AI/ ML will revolutionize medicine by making diagnosis and treatment more accessible and more effective.
FDA has regulated medical software by means of regulations and guidance for years, however, AI/ML programs fall outside the scope of these regulations and guidances.
This happens because FDA approves the final, validated version of the software. The point of AI/ML is to learn and update following deployment to improve performance. Thus the field version of the software is no longer the validated approved version.
We will discuss the current regulatory requirements, how they don’t control AI/ML adequately, and approaches FDA is considering for regulation in the near future. Your development program should conform to these concepts now because, with some modifications, they will probably become regulations.
Following a discussion of possible future regulations, we will discuss, based on recently approved De Novo applications, how to get your AI/ML program approved now. Necessary submission documentation will be explained.
This webinar is not a programming course but will explain the present and future regulatory requirements for AI/ML.
WHY SHOULD YOU ATTEND?
It is not clear how to get AI/ML programs approved. The current regulatory requirements don’t control AI/ML adequately.
We will discuss the approaches FDA is considering for regulation in the near future and how to get your AI/ML program approved by FDA now.
Necessary submission documentation will be explained Attendees will receive a multipage outline and checklist.
AREA COVERED
- Total product life cycle approach to AI/ ML design
- Application of FDA software Pre Cert program to AI/ ML
- FDA discussion paper on AI/ML
- Database management
- QC of datasets
- Algorithm updating
- Reference standard development
- Standalone performance testing
- Clinical performance testing
- Data enrichment
- Emphasis on "explainability"
- Additional labeling requirements
- Cybersecurity
WHO WILL BENEFIT?
Managers, Supervisors, Directors, and Vice-Presidents in the areas of:
- Software Engineers
- Engineers
- Regulatory Personnel
- Quality Assurance Personnel
- Marketing
- Management
It is not clear how to get AI/ML programs approved. The current regulatory requirements don’t control AI/ML adequately.
We will discuss the approaches FDA is considering for regulation in the near future and how to get your AI/ML program approved by FDA now.
Necessary submission documentation will be explained Attendees will receive a multipage outline and checklist.
- Total product life cycle approach to AI/ ML design
- Application of FDA software Pre Cert program to AI/ ML
- FDA discussion paper on AI/ML
- Database management
- QC of datasets
- Algorithm updating
- Reference standard development
- Standalone performance testing
- Clinical performance testing
- Data enrichment
- Emphasis on "explainability"
- Additional labeling requirements
- Cybersecurity
Managers, Supervisors, Directors, and Vice-Presidents in the areas of:
- Software Engineers
- Engineers
- Regulatory Personnel
- Quality Assurance Personnel
- Marketing
- Management
Speaker Profile

Edwin Waldbusser, is a consultant retired from industry after 20 years in management of development of medical devices (5 patents). He has been consulting in the areas of design control, risk analysis and software validation for the past 8 years. Mr. Waldbusser has a BS in Mechanical Engineering and an MBA. He is a Lloyds of London certified ISO 9000 Lead Auditor and a member of the Thomson Reuters Expert Witness network.
Upcoming Webinars

Essential Metrics to Measure Accounts Receivable Health

Bad Standard Operating Procedures (SOPs) - Bad Training: Ga…


Three Key Risk Assessments in Your ERM Program - ERM IT and…

HR Metrics & Analytics 2022: Update on Strategic Planning, …

Recent UPDATES to the Rules Stop Payments vs Unauthorized E…

Financial Projections for Determining Long-Term Cash Flow R…

Data Modelling and Analysis with Excel Power Pivot


Impact Assessments For Supplier Change Notices

How to Write Contracts for Procurement Professionals

FDA Regulation of Artificial Intelligence/ Machine Learning

Stay Interviews: A Powerful Engagement and Retention Tool



Harassment, Bullying, Gossip, Confrontational and Disruptiv…





FORM I-9 2022: ICE Announces New Extension Date and Require…

Establishing a Robust Supplier Management Program

Travel and Expense Policy Development and Automation

With Mandatory Paid Leave Gaining Ground, Is It Time To Do …

Project Management for Non-Project Managers



Implementing an Effective Human Error Reduction Program

How to prepare an effective audit manual for an internal au…

CMO Supplier Quality Agreements: How to Comply with new FDA…


Form 1099 Update 2022: Latest Forms, Rules and Reporting Re…

21 CFR Part 11 - Compliance for Electronic Records and Sign…

Managing Toxic & Other Employees Who have Attitude Issues

The Importance of Packaging and Labeling in Pharmaceutical …

I-9 Audits: Strengthening Your Immigration Compliance Strat…


The Top Ten Excel Functions Everyone Should Know